D.C. Circ. Ponders $600M Rebate Switch Against Mallinckrodt

A panel of D.C. Circuit judges on Thursday mulled over whether or not drugmaker Mallinckrodt should pay more than $600 million for Medicare back rebates in a dispute over a filing...

Already a subscriber? Click here to view full article